Tag: fentanyl market share

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Fentanyl Market from 2024 to 2033?

The fentanyl market has experienced strong growth in recent years. It is projected to grow from $15.14 billion in 2023 to $16.22 billion in 2024, at a CAGR of 7.2%. Growth is driven by pain management needs, medical procedures and surgeries, cancer pain management, and the aging population.

The fentanyl market is expected to grow to $20.79 billion by 2028, at a CAGR of 6.4%. This growth is driven by increasing chronic pain cases, oncology therapies, surgical procedures, public health initiatives, and new drug approvals. Major trends include drug formulation advancements, detection innovations, public health strategies, and pharmaceutical growth.

Claim Your Free Sample of the Global Fentanyl Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13237&type=smp

What Key Factors Are Fueling the Growth of the Fentanyl Market?

The rising prevalence of chronic diseases is expected to drive the fentanyl market. Fentanyl is primarily used to manage severe pain in chronic disease patients. In September 2022, the World Health Organization reported that non-communicable diseases (NCDs) were responsible for 74% of global deaths, with 41 million fatalities annually. Additionally, in August 2023, the British Heart Foundation reported an increase in deaths from coronary heart disease in the UK, from 64,170 in 2020 to 65,579 in 2021. Thus, the growing burden of chronic diseases is propelling the fentanyl market’s growth.

What Are the Major Segments of the Fentanyl Market?

1) By Type: Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)

2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain

3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users

What New Trends Are Transforming the Fentanyl Market?

In the fentanyl market, companies are developing products like Opvee to cater to larger customer bases and improve sales. Opvee, a nasal spray, received FDA approval in May 2023 by Indivior PLC to treat opioid overdoses, including those caused by fentanyl. The spray works by preventing the effects of opioids on the brain, aiding in restoring respiration and blood pressure during emergencies.

Order Now for Fast Delivery of Your Fentanyl Market Report!

https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report

Which Regions Are Driving Growth in the Fentanyl Market?

North America was the largest region in the fentanyl market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Fentanyl Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the fentanyl market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Fentanyl Market Include

1. Fentanyl Market Executive Summary

2. Fentanyl Market Segments

3. Fentanyl Market Size And Template Market Growth Rate

4. Key Fentanyl Market Trends

5. Major Fentanyl Market Drivers

……

25. Key Mergers And Acquisitions In The Fentanyl Market

26. Top Fentanyl Companies

27. Fentanyl Market Opportunities And Strategies

28. Fentanyl Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Alopecia Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/alopecia-global-market-report

Hemophilia Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hemophilia-global-market-report

Pheochromocytoma Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pheochromocytoma-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Fentanyl Global Market Report 2024, the fentanyl market is expected to show significant growth in the forecast period.

Rising Incidence Of Chronic Diseases Drives Growth In The Fentanyl Market

• Understanding Chronic Diseases: Chronic diseases persist over a long period, often throughout a person’s life, and are a leading cause of mortality globally.
• Fentanyl’s Role: Fentanyl is pivotal in managing severe, persistent pain associated with chronic diseases.
• Global Health Impact: Non-communicable diseases (NCDs) account for 74% of global deaths annually, emphasizing the need for effective pain management solutions like fentanyl.

Major Players and Market Dynamics

• Market Dominance: Key companies in the fentanyl market include Pfizer Inc., Johnson & Johnson, Sinopharm Group, and Merck & Co. Inc., among others.
• Diverse Offerings: These companies offer a range of fentanyl products catering to various medical needs.
• Strategic Acquisitions: SK Capital Partners LP’s acquisition of Apotex Pharmaceutical Holdings Inc. underscores a strategic move to expand global reach and focus on low-cost drugs.

View More On The Fentanyl Market Report 2024 – https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report

Increasing Focus On Product Approvals To Gain The Revenues

• Innovation Drive: Major players are investing in R&D to develop innovative products like Opvee, a nasal spray for opioid overdose.
• Regulatory Nod: Indivior PLC’s Opvee received FDA approval in May 2023, showcasing the importance of regulatory approvals in driving market growth.
• Clinical Impact: Opvee’s ease of administration as a nasal spray addresses critical needs in emergency opioid overdose situations, potentially saving lives.

Sk Capital Partners Expands Apotex Pharmaceutical Holdings By Focusing On Global Health And Low-Cost Drugs

• Strategic Acquisition: SK Capital Partners LP’s acquisition of Apotex Pharmaceutical Holdings Inc. aims to diversify product lines and strengthen global health initiatives.
• Canadian Influence: The move positions Apotex as a prominent Canadian global health firm with a focus on affordable medication solutions.
• Transdermal Systems: Apotex Pharmaceutical Holdings Inc. specializes in fentanyl transdermal systems, contributing to the diversity of fentanyl delivery methods.

Market Segmentation and Regional Outlook

• Segment Breakdown: The fentanyl market is segmented by type (injections, transdermal systems), application (anesthesia, analgesia), and end-user (hospitals, clinics, etc.).
• Regional Analysis: North America led the fentanyl market in 2023, with Asia-Pacific poised for significant growth in the forecast period.

Forecasting Future Trends

• Projected Growth: The fentanyl market is expected to reach $20.79 billion by 2028, driven by factors such as rising chronic pain cases and expanding oncology therapies.
• Technological Advancements: Innovations in drug formulations and detection technologies are anticipated to shape market trends.
• Public Health Initiatives: Emphasis on harm reduction strategies and international collaboration will influence market dynamics.

Conclusion
The fentanyl market’s robust growth trajectory underscores its pivotal role in addressing the escalating burden of chronic diseases worldwide. With innovative product developments, strategic acquisitions, and a focus on regulatory approvals, major players are poised to capitalize on emerging opportunities. As the market continues to evolve, technological advancements and concerted efforts in public health initiatives will shape its future landscape, catering to the evolving needs of patients and healthcare providers alike.

Request A Sample Of The Global Fentanyl Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=13237&type=smp